@misc{misc, title = {{Immunogenicity of SARSCoV2 Third Dose Vaccine Strategies in Immunocompromised Patients with Suboptimal Immunity Following Two Doses (OCTAVE-DUO): An Open-Label, Multi-Centre, Randomised, Controlled Phase III Trial}}, url = {{https://doi.org/10.2139/ssrn.4626869 }}, year = {{2023}}, month = {{1}}, author = {{Goodyear CS and Patel A and Barnes E and willicombe M and Siebert S and de Silva TI and Snowden JA and Lim S and Bowden S and Billingham LJ and Richter AG et al}}, doi = {{10.2139/ssrn.4626869}}, note = {{Accessed on 2026/11/16}}}